The National Institutes of Health (NIH) campuses host a variety of events that inform, challenge, and unite the biomedical research community. IRP investigators lead or participate in many of these events, and they regularly present their work at scientific conferences at the NIH and around the world. We invite you to learn about (and possibly join us in) some of our upcoming events. Unless otherwise noted, times listed are Eastern Standard Time (EST).
In this presentation, Dr. Scholz will discuss her lab's approach to tackling complex neurodegenerative diseases using modern genomic tools, focusing on Lewy body dementia, a major research area in her lab. She will showcase how we have gained crucial insights into the genetic architecture of this understudied form of dementia by applying genome sequencing and transcriptomic analyses. By integrating multi-omic data and employing cutting-edge analytical methodologies within a systems biology framework, Dr. Scholz's research team has been able to identify risk genes and understand their functional consequences.
The central theme of the Scholz lab’s work on neurodegenerative diseases is to pinpoint molecular information that is particularly relevant for translational applications. This includes highlighting critical pathways commonly affected across the neurodegenerative disease spectrum, identifying opportunities for drug repurposing, and delineating targets for therapeutic development. Her research team's ultimate goal is to translate genomic advances from the lab into clinical practice and trials, thereby improving outcomes for patients with neurodegenerative diseases.
For decades, the incidence of thyroid cancer increased rapidly in the U.S. and worldwide. Increased diagnostic scrutiny ('overdiagnosis') has been established as the main factor underlying the steep rise in small, localized ('low-risk') papillary thyroid cancers, although lifestyle or environmental causes may have played a more minor role. Coinciding with rising incidence trends, an increasing proportion of low-risk thyroid cancers in the U.S. received more aggressive treatments, including total thyroidectomy and radioactive iodine ablation, raising concerns about treatment-related adverse effects and quality of life. In this talk, Dr. Kitahara will discuss the results of her research aiming to understand changes in thyroid cancer incidence trends and clinical management, as well as the impact of these changes on short- and long-term health outcomes.
The NIH Graduate Student Research Symposium is the premier event for NIH graduate students to showcase their research to the NIH community. All graduate students performing their Ph.D. dissertation research within the NIH Intramural Research Program are highly encouraged to present, and all members of the NIH community are invited to attend.
This year's symposium will feature:
Poster presentations on the dissertation research of NIH graduate students.
Oral presentations by current NIH graduate students selected based on their abstract submission.
An elevator pitch competition by NIH Graduate Students.
The NIH Graduate Student Research Awards (NGSRA) — travel/educational awards presented to the top poster presenters, judged by NIH Postdoctoral fellows, Staff Scientists, and Staff Clinicians. At least one of these awards will be reserved exclusively for a poster submitted in the "New Proposal" category.
Graduation ceremony honoring students who have recently defended their dissertations.
Presentation of the annual GPP Outstanding Mentor Awards.
Rare Disease Day® takes place worldwide, typically on or near the last day of February each year, to raise awareness among policymakers and the public about rare diseases and their impact on patients’ lives. This year, NIH's National Center for Advancing Translational Sciences (NCATS) and the US Food and Drug Administration (FDA), both agencies within the Department of Health and Human Services, will sponsor a shared Rare Disease Day event as part of this global observance. FDA-NIH Rare Disease Day aims to provide the rare disease community — patients, caregivers, families, patient advocate groups, researchers, clinicians, health care providers, and trainees/students — with information relevant to their lived experiences, including activities by FDA and NIH that promote research and product development for this underserved population.
The goals of FDA-NIH Rare Disease Day are to:
Demonstrate the NIH and FDA commitment to advancing research and regulatory support for people affected by rare diseases.
Highlight NIH and FDA supported rare diseases research and the development of diagnostics and treatments.
Initiate a mutually beneficial dialogue among the rare diseases community.
Exchange the latest rare diseases information with stakeholders to advance research and therapeutic efforts.
Shine a spotlight on stories told by patients living with a rare disease, their caregivers, and their communities.
FDA-NIH Rare Disease Day seeks to bring together a broad audience including patients, patient advocates, caregivers, health care providers, researchers, trainees, students, industry representatives, and government staff. The event will feature panel discussions, rare diseases stories, in-person exhibitors and scientific posters, and an art exhibition. It is free and open to the public.
Sleep health influences every facet of human function and is essential for optimal physical and mental health. Since the drive to sleep is not entirely endogenous and is affected by exogenous features of the environment, Dr. Jackson's research group focuses on identifying the social, behavioral, and biological pathways linking modifiable physical (e.g., light and temperature) and social (e.g., psychosocial stress) environmental factors to downstream sleep and subsequent health outcomes. During this presentation, Dr. Jackson will summarize epidemiological evidence illustrating how disparate exposure to various environmental factors contribute to disparities in sleep health and subsequent cardiometabolic health.
The goal of the NCI RNA Biology Initiative is to establish a collaborative environment that promotes the swift exchange of information and expertise regarding the structure, function, and biological significance of RNA. Our objective is to leverage this collective knowledge to advance the development of novel diagnostics and therapies. We actively foster synergistic collaborations among NCI and NIH intramural investigators, as well as between our researchers and the broader RNA community.
The symposium offers the opportunity to learn more about the current status of RNA biology in development and disease, share research, network with leading figures in the field and discuss the use and implications of these advances for clinical applications.
Organized by the NCI RNA Biology Initiativethis symposium will bring together internationally renowned experts in the field of RNA biology, with the focus on:
RNA Processing
RNA Structure and Mechanism
Non-classical RNAs
RNA Therapy
This page was last updated on Friday, October 20, 2023
